Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance. Emerging research reveals that the ...
A groundbreaking study from Tata Memorial Hospital shows that using ultra-low doses of nivolumab, an immunotherapy drug, can effectively treat cancer while drastically reducing costs by 90%. This ...
Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance.
Doctors debunk viral myths about cancer diets, clarifying that sugar does not directly cause cancer and fasting cannot prevent it. Experts stress balanced nutrition and evidence-based treatment for ...
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator GNTbm-38, with global rights for cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results